At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CRMD CorMedix Inc.
Market Closed 05-31 16:00:00 EDT
5.27
-0.01
-0.19%
盘后5.28
+0.01+0.19%
18:27 EDT
High5.40
Low5.19
Vol349.72K
Open5.30
D1 Closing5.28
Amplitude3.91%
Mkt Cap289.64M
Tradable Cap286.80M
Total Shares54.96M
T/O1.84M
T/O Rate0.64%
Tradable Shares54.42M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
CorMedix Shares Rise on Multiyear DefenCath Supply Deal
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.